Goodman told The Hollywood Reporter of what to expect in episode 2
FLORA LICHTMAN: Whats the third way
Behnken design of experiments of polycaprolactone nanoparticles loaded with irinotecan hydrochloride
Compounding advocates say that, although the drugs are not FDA-approved, they are still subject to rigorous quality control, in part due to post-2012 rule changes
For example, in a patient with intentional overdose who is also on a GLP-1 agonist, the time to peak concentration of co-ingested agents may be prolonged, complicating risk assessment, decontamination decisions, and timing of antidotal therapies
Multiple systematic reviews and meta-analyses of RCTs have been conducted, typically confronting: Very low thyroid cancer event rates Heterogeneous ascertainment across trials Insufficient duration for long-latency outcomes Interpretation: The absence of strong signals is reassuring for short-to-mid-term risk